Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ironwood Pharmaceuticals, Inc.    IRWD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about IRONWOOD PHARMACEUTICALS,
11/08 IRONWOOD PHARMACEUTICALS : to Present at Credit Suisse 26th Annual Healthcare Co..
11/08 IRONWOOD PHARMACEUTICALS : Provides Third Quarter 2017 Investor Update
11/02 IRONWOOD PHARMACEUTICALS : reports 3Q loss
11/02 IRONWOOD PHARMACEUTICALS : Provides Third Quarter 2017 Investor Update
11/01 IRONWOOD PHARMACEUTICALS : to Present at Credit Suisse 26th Annual Healthcare Co..
10/30 IRONWOOD PHARMACEUTICALS : Highlights Breadth of Gout Research to be Presented a..
10/30 IRONWOOD PHARMACEUTICALS : Highlights Breadth of Gout Research to be Presented a..
10/24 IRONWOOD PHARMACEUTICALS : to Host Third Quarter 2017 Investor Update Call
10/19 IRONWOOD PHARMACEUTICALS : to Host Third Quarter 2017 Investor Update Call
10/18 IRONWOOD PHARMACEUTICALS : Presenting Linaclotide Data at the World Congress of ..
10/16 IRONWOOD PHARMACEUTICALS : Presenting Linaclotide Data at the World Congress of ..
09/08 IRONWOOD PHARMACEUTICALS : Announces Leadership Change
09/08 VERTEX PHARMACEUTICALS : Appoints Tom Graney as Senior Vice President and Chief ..
09/06 IRONWOOD PHARMACEUTICALS : Announces Leadership Change
08/31 IRONWOOD PHARMACEUTICALS : to Present at Upcoming September Investor Conferences
More most relevant news
All news about IRONWOOD PHARMACEUTICALS,
11/09 IRONWOOD PHARMACEUTICALS : Highlights Breadth of Gout Research to be Presented a..
11/08 IRONWOOD PHARMACEUTICALS : to Present at Credit Suisse 26th Annual Healthcare Co..
11/08 IRONWOOD PHARMACEUTICALS : Provides Third Quarter 2017 Investor Update
11/07 Market Trends Toward New Normal in Public Service Enterprise Group, Rigel Pha..
11/02 IRONWOOD PHARMACEUTICALS : Management's Discussion and Analysis of Financial Con..
11/02 IRONWOOD PHARMACEUTICALS : reports 3Q loss
11/02 IRONWOOD PHARMACEUTICALS INC : Results of Operations and Financial Condition, Fi..
11/02 IRONWOOD PHARMACEUTICALS : Provides Third Quarter 2017 Investor Update
11/01 IRONWOOD PHARMACEUTICALS : to Present at Credit Suisse 26th Annual Healthcare Co..
10/30 IRONWOOD PHARMACEUTICALS : Highlights Breadth of Gout Research to be Presented a..
More news
Sector news : Biotechnology & Medical Research - NEC
11/16 Recovery rally for European stocks leaves oil sector behind
11/13 Poor earnings updates keep European shares at seven-week low
11/13DJNOVARTIS : Vision Drug Shows Positive Results in Phase 3 Trials
11/03 Prosecutors search Metro offices in insider trading probe
11/01DJAs Experimental Treatments Grow, Families Face Tough Choices
10/31 Pfizer expects broad interest for consumer health business
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
11/15 YOUR DAILY PHARMA SCOOP : Portola Ahead Of Catalysts, AstraZeneca Gets Two FDA A..
11/14 SYNERGY PHARMA : Financing Methods Provide Long-Term Opportunity At A Risk
11/10 SYNERGY PHARMACEUTICALS Q3 : Delivering The Goods
11/04 Ironwood Pharmaceuticals' (IRWD) CEO Peter Hecht on Q3 2017 Results - Earning..
11/03 Equity offering registration roundup - healthcare
11/03 Ironwood Pharmaceuticals, Inc. 2017 Q3 - Results - Earnings Call Slides
Financials ($)
Sales 2017 290 M
EBIT 2017 -115 M
Net income 2017 -126 M
Debt 2017 310 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 9,07x
EV / Sales 2018 7,03x
Capitalization 2 323 M
Chart IRONWOOD PHARMACEUTICALS,
Duration : Period :
Ironwood Pharmaceuticals,  Technical Analysis Chart | IRWD | US46333X1081 | 4-Traders
Technical analysis trends IRONWOOD PHARMACEUTICALS,
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 16,9 $
Spread / Average Target 9,1%
EPS Revisions
Managers
NameTitle
Peter M. Hecht Chief Executive Officer & Director
Terrance G. McGuire Chairman
Gina R. Consylman CFO, CAO, Controller & VP-Finance
Mark G. Currie Chief Scientific Officer & Senior Vice President
Brian M. Cali Senior VP-Preclinical, Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
IRONWOOD PHARMACEUTICALS, INC.1.44%2 323
CELLTRION, INC.--.--%24 558
INCYTE CORPORATION5.19%22 258
IQVIA HOLDINGS INC37.36%22 074
LONZA GROUP59.52%19 560
ALNYLAM PHARMACEUTICALS, INC.240.57%12 538